TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
IFRX

InflaRx N.V.

Healthcare · Biotechnology

1.90$ -2.1% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns InflaRx N.V. (IFRX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 66.6% of the shares are freely tradable; institutional investors hold 34.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 34.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.9%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 66.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 9.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 147Mio.

Largest Shareholders

Institutions

Institutions IFRX
Name Stake (%) Shares Change (%) Date
TCG Crossover Management, LLC 9.84 14,500,000 +0.0 06/30/2026
Suvretta Capital Management, LLC 5.38 7,933,910 +0.0 03/31/2026
Spruce Street Capital LP 3.63 5,352,198 +0.0 06/30/2026
683 Capital Management LLC 2.25 3,315,000 +0.0 03/31/2026
Great Point Partners LLC 2.07 3,046,557 +0.0 06/30/2026
Squadron Capital Management LLC 1.36 2,000,000 +0.0 06/30/2026
Bank of America Corp 1.34 1,975,000 -20.2 03/31/2026

Funds

Funds IFRX
Name Stake (%) Shares Change (%) Date
Fidelity Small Cap Growth 2.23 3,289,530 +0.0 06/30/2026
Fidelity Advisor Biotechnology I 2.17 3,196,071 +0.0 07/31/2026
Fidelity Small Cap Growth K6 1.14 1,677,740 +0.0 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?